Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Malignant Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02621658
What this trial is testing

Clear Liquid vs Liberalized Diet in Preparation for Colonoscopy

Who this might be right for
Colorectal Cancer
San Antonio Military Medical Center 1,000
Not applicableUnknownNCT05066048
What this trial is testing

Intestinal Microecological Dysregulation Caused by Appendectomy Increases the Risk of Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 300
Not applicableUnknownNCT05990569
What this trial is testing

Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia

Who this might be right for
HemorrhoidsAnal Fissure and FistulaPerianal Abscess+3 more
Nepal Mediciti Hospital 60
Not applicableNot Yet RecruitingNCT06066931
What this trial is testing

Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE

Who this might be right for
Rectum Cancer
Kuban State Medical University 150
Not applicableActive Not RecruitingNCT04136002
What this trial is testing

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Who this might be right for
Colorectal Cancer
Guardant Health, Inc. 44,467
Testing effectiveness (Phase 2)Study completedNCT02723253
What this trial is testing

Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 18
Not applicableUnknownNCT04728139
What this trial is testing

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Assiut University 90
Not applicableStudy completedNCT01405430
What this trial is testing

Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab

Who this might be right for
Colorectal CancerMetastasis
Centre Leon Berard 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05205330
What this trial is testing

Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers

Who this might be right for
Refractory Metastatic Colorectal CancerSolid TumorMetastatic Microsatellite-stable Colorectal Cancer+3 more
Rottapharm Biotech 107
Not applicableStudy completedNCT02879370
What this trial is testing

Transanal Inspection and Management of Low ColoRectal Anastomosis Performed With a New Technique

Who this might be right for
Anastomotic Leak
University of Rome Tor Vergata 53
Not applicableLooking for participantsNCT07068529
What this trial is testing

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC

Who this might be right for
Colorectal Cancer
Shanghai Minimally Invasive Surgery Center 250
Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Testing effectiveness (Phase 2)UnknownNCT05970302
What this trial is testing

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Who this might be right for
TislelizumabBevacizumabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableUnknownNCT06145230
What this trial is testing

A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups

Who this might be right for
Colorectal CancerAge Problem
Wang Guiyu 430
Not applicableStudy completedNCT01196130
What this trial is testing

Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 1,275
Testing effectiveness (Phase 2)UnknownNCT03093129
What this trial is testing

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Who this might be right for
Colorectal Cancer
The 108 Military Central Hospital 200
Not applicableLooking for participantsNCT06837831
What this trial is testing

Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin

Who this might be right for
Rectal Cancer, RadiotherapyAnal PainAcute Radiation Dermatitis+1 more
Qianfoshan Hospital 274
Next Page